Chikungunya Vaccine in Clinical Trial

News   Jun 07, 2017 | Original Story from NIAID

 
Clinical Trial of Vaccine for Chikungunya Virus Begins
 
 
 

RELATED ARTICLES

Computation and Chemistry Combine to Create World-First Auxetic Protein

News

A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.

READ MORE

Robots Grow Mini-Organs From Human Stem Cells

News

A robotic approach to mass-producing organoids could accelerate regenerative medicine research and drug discovery.

READ MORE

Resistance to Antifungals Could Lead to Disease and Global Food Shortages

News

Growing levels of resistance to antifungal treatments could lead to increased disease outbreaks and affect food security around the world.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE